M.S. is a disease of the brain and spinal cord that affects almost a million people in the United States. About 1,200 here in ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

The Stand Up for Science rallies are a response to the Trump administration’s actions, which critics see as a threat to ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.

Approximately 19 in every 100,000 people in the Emirates are affected by MS, with the condition often beginning in young ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...